Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

706
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
706
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

734
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
734
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

503
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
503
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

714
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
714
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

963
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
963
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

The Journal of biological chemistry·2026
Same author

Substrate and target selectivity of 4'-fluoroadenosine against viral and host polymerases.

bioRxiv : the preprint server for biology·2026
Same author

The Q226H Mutation in Avian H5N1 Hemagglutinin Mediates a Path towards Structural Adaptation in Humans.

bioRxiv : the preprint server for biology·2026
Same author

Viprutoxin, a snake venom serine proteinase inhibits platelet aggregation and selectively targets A549 cancer cells invitro.

Toxicon : official journal of the International Society on Toxinology·2026
Same author

Preferential remdesivir triphosphate incorporation by SARS-CoV-2 polymerase is altered to ATP by the S759A mutation.

Communications biology·2026
Same author

Protocol to investigate human mitochondrial transcription initiation by integrating biochemical and cryo-EM approaches.

STAR protocols·2026

Related Experiment Video

Updated: May 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Robust inference for mixed censored and binary response models with missing covariates.

Angshuman Sarkar1, Kalyan Das2, Sanjoy K Sinha3

  • 1Novartis Healthcare Pvt. Ltd., Hyderabad, India.

Statistical Methods in Medical Research
|October 11, 2013
PubMed
Summary
This summary is machine-generated.

This study introduces a robust statistical model for analyzing complex biomedical data with mixed outcomes, censored continuous responses, and missing covariates. The new method offers reliable parameter estimation resistant to outliers, crucial for epidemiological and clinical research.

Keywords:
binary modelcensored regression modelexpectation maximization algorithmmetropolis algorithmmissing datarobust estimation

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Related Experiment Videos

Last Updated: May 7, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

9.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Trials

Background:

  • Biomedical and epidemiological studies frequently encounter complex data types, including mixed discrete and continuous outcomes.
  • Technical issues can lead to censored continuous responses and incomplete covariate data, complicating analysis.
  • Existing statistical models may not adequately address these combined complexities, necessitating robust methodologies.

Purpose of the Study:

  • To develop a generalized statistical framework for robustly analyzing mixed discrete and continuous outcomes with censored data and missing covariates.
  • To introduce robust maximum likelihood estimators that are resistant to outliers in complex datasets.
  • To provide a computationally feasible approach for estimating model parameters in high-dimensional settings.

Main Methods:

  • Development of a generalized statistical model accommodating mixed, censored, and incomplete data.
  • Proposal of robust maximum likelihood estimators with discussion of their asymptotic properties.
  • Implementation of a Monte Carlo method using the Metropolis algorithm to approximate estimators and overcome computational challenges.

Main Results:

  • The proposed methodology provides a full-scale robust analysis for complex mixed-effects models.
  • Robust maximum likelihood estimators demonstrate resistance to data outliers.
  • Simulations confirm the empirical properties of the developed estimators.

Conclusions:

  • The developed robust statistical method effectively handles complex data structures common in biomedical research.
  • The Monte Carlo approach facilitates practical application of robust estimation in high-dimensional scenarios.
  • The method's utility is demonstrated through an application to clustered diabetes clinical trial data on blood sugar levels.